Literature DB >> 12205401

Ventilator-induced lung injury.

Jean-Damien Ricard1, Didier Dreyfuss, Georges Saumon.   

Abstract

The clinical relevance of experimental ventilator-induced lung injury has recently received a resounding illustration by the Acute Respiratory Distress Syndrome Network trial that showed a 22% reduction of mortality in patients with acute respiratory disease syndrome when lung mechanical stress was lessened by tidal volume reduction during mechanical ventilation. This clinical confirmation of the concept of ventilator-induced lung injury has also undisputedly substantiated the experimental observation that excessive tidal volume and/or end-inspiratory lung volume is the main determinant of ventilator-induced lung injury. More recently, attention has focused on the roles and implication in the pathogenesis of ventilator-induced lung injury of inflammatory cells and mediators that may be activated and released either in the alveolar space or in the systemic circulation because of the rupture of the alveolar-capillary barrier and on the cellular response to mechanical stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205401     DOI: 10.1097/00075198-200202000-00003

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  18 in total

Review 1.  Permissive hypercapnia--role in protective lung ventilatory strategies.

Authors:  John G Laffey; Donall O'Croinin; Paul McLoughlin; Brian P Kavanagh
Journal:  Intensive Care Med       Date:  2004-01-14       Impact factor: 17.440

2.  Hypercapnic acidosis in ventilator-induced lung injury.

Authors:  Vanya Peltekova; Doreen Engelberts; Gail Otulakowski; Satoko Uematsu; Martin Post; Brian P Kavanagh
Journal:  Intensive Care Med       Date:  2010-03-06       Impact factor: 17.440

3.  Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation.

Authors:  Peter Dahlem; Albert P Bos; Jack J Haitsma; Marcus J Schultz; Joost C M Meijers; Burkhard Lachmann
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

4.  Acute lung injury and acute respiratory distress syndrome.

Authors:  Maximillian Ragaller; Torsten Richter
Journal:  J Emerg Trauma Shock       Date:  2010-01

5.  Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-04-01

6.  Occult pneumothorax in the mechanically ventilated trauma patient.

Authors:  Chad G Ball; S Morad Hameed; Dave Evans; John B Kortbeek; Andrew W Kirkpatrick
Journal:  Can J Surg       Date:  2003-10       Impact factor: 2.089

Review 7.  Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome.

Authors:  Nuria E Cabrera-Benitez; John G Laffey; Matteo Parotto; Peter M Spieth; Jesús Villar; Haibo Zhang; Arthur S Slutsky
Journal:  Anesthesiology       Date:  2014-07       Impact factor: 7.892

8.  A pilot prospective study on closed loop controlled ventilation and oxygenation in ventilated children during the weaning phase.

Authors:  Philippe Jouvet; Allen Eddington; Valérie Payen; Alice Bordessoule; Guillaume Emeriaud; Ricardo Lopez Gasco; Marc Wysocki
Journal:  Crit Care       Date:  2012-05-16       Impact factor: 9.097

9.  Bedside measurement of changes in lung impedance to monitor alveolar ventilation in dependent and non-dependent parts by electrical impedance tomography during a positive end-expiratory pressure trial in mechanically ventilated intensive care unit patients.

Authors:  Ido G Bikker; Steffen Leonhardt; Dinis Reis Miranda; Jan Bakker; Diederik Gommers
Journal:  Crit Care       Date:  2010-05-30       Impact factor: 9.097

10.  The Association of Fever and Antipyretic Medication With Outcomes in Mechanically Ventilated Patients: A Cohort Study.

Authors:  Emily M Evans; Rebecca J Doctor; Brian F Gage; Richard S Hotchkiss; Brian M Fuller; Anne M Drewry
Journal:  Shock       Date:  2019-08       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.